AMNEAL PHARMACEUTICALS INC - CLASS A (AMRX)

(EBS) StockTEVA, AMRX, AMPH, INDV, SMMT, HKMPF, BVNRY, REGN, VALN, BVNKF, HKMPY, INRLF, TEVJF · Robert J. Lake ... Emergent BioSolutions remains under significant pressure, with persistent revenue, margin, and earnings declines across both Naloxone and Medical Counter-measures (MCM) segments.

Shares of pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) jumped 5.7% in the afternoon session after the U.S. Food and Drug Administration (FDA) approved its romidepsin injection solution, a treatment used in certain lymphoma patients.

Track AMRX Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. Get Amneal Pharma news, earnings, and stock analysis — all in one place at TipRanks.

The 4 generic pharmaceuticals stocks we track reported a mixed Q4. As a group, revenues beat analysts’ consensus estimates by 4.8%. Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 7.6% since the latest earnings results. Founded in 2002 and growing …

Who Owns Amneal Pharma? Discover who is the most significant shareholders of Amneal Pharma are and learn how they control a substantial portion of the company’s shares.